S&E bio Co.
Latest round
- Series A
Last raised
- Dec 2022
Total raised
- $9.7M
Investors
- 7
About S&E bio Co.
, Ltd. focuses on developing innovative exosome-based therapies to address intractable diseases, enhancing treatment options for acute ischemic stroke and other neurological conditions., Ltd. specializes in advancing cellular therapies, particularly exosome-based solutions., Ltd. excels in creating exosome-based therapies aimed at treating intractable diseases, with its primary product SNE-101 targeting acute ischemic stroke by promoting neurovascular regeneration while reducing oxidative stress and inflammation. The company serves hospitals and healthcare providers in South Korea, with plans to expand its offerings to broader Asian markets, focusing on innovative cell-free therapies for neurological conditions., Ltd. generates revenue through partnerships with healthcare institutions, integrating its exosome-based therapies into clinical practices post-approval. The company follows a B2B model, collaborating with hospitals to conduct clinical trials. Its pricing strategy reflects the innovative nature of its flagship product SNE-101, while ongoing research collaborations enhance the marketability of its therapies., Ltd. plans to initiate clinical trials for Evimir-Stroke, targeting acute stroke treatments. This strategic growth is aligned with the company's goal to penetrate new markets across Asia in the forthcoming years.
Who invested in S&E bio Co.
7 investors across 2 rounds
See all investors in S&E bio Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about S&E bio Co.
Who invested in S&E bio Co.?
S&E bio Co. has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has S&E bio Co. raised?
S&E bio Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did S&E bio Co. last raise money?
S&E bio Co.'s most recent round on record is a Series A, in Dec 2022.
What does S&E bio Co. do?
S&E bio Co. is a biotechnology company.
Where is S&E bio Co. headquartered?
S&E bio Co. is headquartered in Seoul, South Korea.
Which VCs invest in companies like S&E bio Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at S&E bio Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like S&E bio Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.